Screener
Corcept Therapeutics CORT Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $9.42M.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's total debt?
- Corcept Therapeutics (CORT) reported total debt of $9.42M in Q2 2026.
- How has Corcept Therapeutics's total debt changed year-over-year?
- Corcept Therapeutics's total debt increased by 42.6% year-over-year, from $6.61M to $9.42M.
- What is the long-term trend for Corcept Therapeutics's total debt?
- Over 5 years (2020 to 2025), Corcept Therapeutics's total debt has grown at a 19.1% compound annual growth rate (CAGR), from $2.55M to $6.11M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Corcept Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude